Alliance for Cancer Gene Therapy shared on X:
“ACGT has awarded a $500,000 grant to Crystal Mackall, MD (Stanford Medicine), to develop a CAR T-cell therapy with a unique remote-control feature to counter some of the obstacles presented by solid tumors.”